Moderna said Thursday it’s developing a booster shot that protects against COVID-19 and the seasonal flu in a single dose. “Our number one priority as a company right now is to bring to market ...

The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna ...

Moderna said it chose the lower-dose booster because it triggered fewer uncomfortable shot reactions such as fever and achiness but also leaves more vaccine available for the global supply.

Moderna says a third booster dose of its COVID-19 vaccine will likely be necessary this fall because of the rapid spread of the Delta variant of the coronavirus.

Moderna submitted its application to the US Food and Drug Administration for emergency use authorization of its updated Covid-19 vaccine booster for use in people age 18 and older, the company ...

Moderna CEO Stéphane Bancel revealed during an interview with “Mornings with Maria” on Thursday when his company’s COVID-19 booster vaccine could be available to the public.

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...

Vaccine maker Moderna announced Monday that its new omicron-targeted booster shot reinforces a key line of immune defense by increasing levels of coronavirus-fighting antibodies that block BA.5.

A study suggested that the updated booster shot produced higher levels of neutralizing antibodies against the Omicron subvariants BA.4 and BA.5 than the first booster, the company said.

Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...

The Food and Drug Administration said Wednesday it has expanded existing warnings on the two leading COVID-19 vaccines about ...